EUVIMED · CrossrefZeitschrift
Journal of Scleroderma and Related Disorders
ISSN 2397-1983 · SAGE Publications
Neueste Artikel
Association between bosentan and reduced detection of precapillary pulmonary hypertension in systemic sclerosis: evidence from a EUSTAR study
VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis
Pathologic differences between systemic sclerosis–associated and idiopathic pulmonary arterial hypertension
Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review
Anti-fibrotic effects of thrombin inhibition in systemic sclerosis-associated interstitial lung disease: Proof of concept
Clinical associations of worsening physical function as measured by HAQ-DI scores in systemic sclerosis
Evaluation of the type D personality and its association with cardiovascular risk and disease-related parameters in patients with systemic sclerosis
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease
National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients
Clinical and ultrasonographic evaluation of efficacy and safety of intralesional injection of autologous platelet-rich plasma in morphea: A comparative case series
Prevalence of and factors independently associated with digital ischemic complications in patients with systemic sclerosis
Systemic sclerosis in Asians: Are there racial differences?
Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Scleredema with biopsy-confirmed cardiomyopathy: A case report
Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients
Epidemiology and trends in survival of systemic sclerosis in Olmsted County (1980–2018): A population-based study
Circulating Gremlin-1 is elevated in systemic sclerosis patients
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement
Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches
Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease
Mortality and morbidity in scleroderma renal crisis: A systematic literature review
Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre
Validity and correlates of the Brief Satisfaction With Appearance Scale for patients with limited and diffuse systemic sclerosis: Analysis from the University of California, Los Angeles Scleroderma Quality of Life Study
Natural history of systemic sclerosis–related interstitial lung disease: How to identify a progressive fibrosing phenotype
Therapeutic molecular targets of SSc-ILD
Treatment of systemic sclerosis–associated interstitial lung disease: Lessons from clinical trials
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States
What can we learn from Fli1 -deficient mice, new animal models of systemic sclerosis?
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
EUVIMED